Asia Healthcare Industry Digest
SEE OTHER BRANDS

The latest healthcare and wellness news from Asia and the Pacific

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on June 3, 2025

L’AVENIR DE LA PRODUCTION ALIMENTAIRE EST FAIT AU CANADA : Le Défi Cultiver l’innovation d’ici offre une subvention de 20 M$ dans le cadre de sa phase de mise à l’échelle pour soutenir la production alimentaire nationale

L’AVENIR DE LA PRODUCTION ALIMENTAIRE EST FAIT AU CANADA : Le Défi Cultiver l’innovation d’ici offre une subvention de 20 M$ dans le cadre de sa phase de mise à l’échelle pour soutenir la production alimentaire nationale

TORONTO, 03 juin 2025 (GLOBE NEWSWIRE) -- Il est plus essentiel que jamais d’assurer au Canada un approvisionnement alimentaire sécuritaire et durable. Poursuivant son engagement de longue date envers l’amélioration du bien-être des Canadiens, la Fondation …

BON Announces Share Repurchase Program for up to US$1.0 Million

BON Announces Share Repurchase Program for up to US$1.0 Million

XI’AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced its board of directors approved a …

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals

25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000 A full 45 percent of persistent babesiosis cases include chronic fatigue Healthcare providers treating patients who present with …

Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.

Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.

NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“SEC”) of a registration statement on …

QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency

QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency

Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue.  WEST PALM BEACH, FL, June 03, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), …

Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics

Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics

BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences, a global leader in the research and intellectual property of premium psilocybin products, has signed an agreement with Johns Hopkins University to exclusively license Johns Hopkins …

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …

Nanox to Participate in Sidoti Small Cap Conference

Nanox to Participate in Sidoti Small Cap Conference

PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will participate in the Sidoti Small Cap Conference to be held …

Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise

Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise

Company to Expand Patented Wellness Approach into High-Growth Cognitive and Restorative Sleep Markets, Emphasizing Scientific Rigor and Unique Formulations SCOTTSDALE, AZ, June 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or …

Press Release:  ASCO: new Sarclisa data support subcutaneous administration with on-body injector

Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector

ASCO: new Sarclisa data support subcutaneous administration with on-body injector New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with …

Communiqué de presse : ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps

Communiqué de presse : ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps

ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps De nouvelles données provenant de deux études cliniques ont démontré que le Sarclisa administré par voie sous-cutanée via un injecteur …

IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study

IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study

Consistent OS Efficacy Benefit Across Multiple Treatment Subgroups Demonstrates IMNN-001’s Ability to Recruit a Powerful Anti-Cancer Immune Response  Results, presented simultaneously in oral presentation at ASCO 2025 and in peer-reviewed Gynecologic …

Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress

Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress

REDWOOD CITY, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell …

Behavidence Becoming Mental Health Infrastructure Backbone for U.S., U.K., and Israeli Governments

Behavidence Becoming Mental Health Infrastructure Backbone for U.S., U.K., and Israeli Governments

Behavidence becomes core mental health infra for US, UK & Israel; powers early detection, suicide prevention …

Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference

PITTSBURGH, June 03, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, in Miami. Krish S. Krishnan …

Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference

Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive …

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the presentation of new …

Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York

Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York

LAFAYETTE, La., June 03, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced it will present at the East …

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHARLESTOWN, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 34,550 restricted …

The MUHC Foundation’s Le Bal Rouge Gala raises $2,106,445 million for innovation in health care at the MUHC’s Glen site

The MUHC Foundation’s Le Bal Rouge Gala raises $2,106,445 million for innovation in health care at the MUHC’s Glen site

MONTREAL, June 03, 2025 (GLOBE NEWSWIRE) -- The MUHC Foundation’s signature gala, Le Bal Rouge, brought together Montreal’s most passionate changemakers in business, philanthropy and health care to celebrate a decade of innovation at the McGill University …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service